- freely available
Deregulation of Interferon Signaling in Malignant Cells
AbstractInterferons (IFNs) are a family of cytokines with potent antiproliferative, antiviral, and immunomodulatory properties. Much has been learned about IFNs and IFN-activated signaling cascades over the last 50 years. Due to their potent antitumor effects in vitro and in vivo, recombinant IFNs have been used extensively over the years, alone or in combination with other drugs, for the treatment of various malignancies. This review summarizes the current knowledge on IFN signaling components and pathways that are deregulated in human malignancies. The relevance of deregulation of IFN signaling pathways in defective innate immune surveillance and tumorigenesis are discussed.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Katsoulidis, E.; Kaur, S.; Platanias, L.C. Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals 2010, 3, 406-418.View more citation formats
Katsoulidis E, Kaur S, Platanias LC. Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals. 2010; 3(2):406-418.Chicago/Turabian Style
Katsoulidis, Efstratios; Kaur, Surinder; Platanias, Leonidas C. 2010. "Deregulation of Interferon Signaling in Malignant Cells." Pharmaceuticals 3, no. 2: 406-418.